Inhibiting 5-Lipoxygenase Prevents Skeletal Muscle Atrophy by Targeting Organogenesis Signaling and Insulin-Like Growth Factor-1

Previously tested Malotilate treatment for liver degeneration, inflammation, and fibrosis was repurposed to investigate effects in skeletal muscle atrophy by utilizing myotube-based models of skeletal muscle atrophy and aging.